Objective: To evaluate background parenchymal enhancement (BPE) and its characteristics, as well as its behavior before and after neoadjuvant chemotherapy (NAC), in both breasts of patients with unilateral breast cancer. Materials and Methods: This was a retrospective, cross-sectional observational study involving a consecutive sample of women with invasive breast cancer who underwent breast magnetic resonance imaging (MRI) between July 2007 and July 2017, as well as undergoing dynamic contrast-enhanced MRI before and after NAC. In both breasts, we evaluated the BPE in accordance with the Breast Imaging Reporting and Data System. We applied logistic regression analysis, and values of p < 0.05 were considered significant. Results: We evaluated 150 women. The mean age was 45.2 years (range, 20-74 years). The variables correlating independently with a high pre-NAC BPE, in the affected and contralateral breasts, were being under 50 years of age (odds ratio [OR] = 6.55; 95% confidence interval [95% CI]: 2.32-18.46, for both breasts) and a post-NAC BPE reduction (OR = 17.75; 95% CI: 4.94-63.73 and OR = 18.47; 95% CI: 5.19-66.49, respectively). Conclusion: Patients with invasive unilateral breast cancer who have a high pre-NAC BPE in both breasts tend to be under 50 years of age and to show a post-NAC reduction in BPE.
This study brings important epidemiological data for the audit of mammographic screening, rare among us. Data have been analyzed as compared to what is recommended by the literature, the detection rate and the percentage of minimal and in situ carcinomas found being comparable to the established values, but with the VPP value lower than the ideal.
Relato de caso ResumoGravidez ectópica na cicatriz de cesárea é a forma mais rara de gravidez ectópica e provavelmente uma das mais perigosas em função dos riscos de ruptura e hemorragia volumosa. Essa situação deve ser diferenciada da gravidez cervical e de abortamento em curso, para que o tratamento apropriado seja imediatamente oferecido. Desde o advento da ultra-sonografia transvaginal, a gravidez ectópica na cicatriz de cesárea pode ser diagnosticada precocemente na gestação e, para isso o ultra-sonografista deve estar familiarizado com e atento aos critérios diagnósticos, especialmente em mulheres com cicatriz de cesárea prévia. Descrevemos aqui um caso de gravidez ectópica em cicatriz de cesárea, cujo diagnóstico foi tardio, havendo apresentação de involução espontânea. AbstractEctopic pregnancy in a cesarean scar is the rarest form of ectopic pregnancy and probably the most dangerous one because of the risk of uterine rupture and massive hemorrhage. This condition must be distinguished from cervical pregnancy and spontaneous abortion in progress, so that the appropriate treatment can be immediately offered. Since the advent of endovaginal ultrasonography, ectopic pregnancy in a cesarean scar can be diagnosed early in pregnancy if the sonographer is familiarized with the diagnostic criteria of this situation, especially in women with previous cesarean scar. Here we describe a case of ectopic pregnancy in a cesarean scar in which the diagnosis was considerably late, with presentation of spontaneous regression.Trabalho realizado no Hospital Estadual de Sumaré -HES, Sumaré (SP) e CDE Diagnóstico por Imagem -Campinas (SP), Brasil.
Biópsia de fragmento em nódulos mamários suspeitos com até 10 mm Core biopsy in suspicious solid breast lesions up to 10 mm ); 49 casos malignos (54,4%) e um caso (1,2%) de material considerado inconclusivo. Essa paciente foi submetida à nova biópsia de fragmento sob controle ultra-sonográfico, dessa vez obtendo-se material conclusivo. Houve concordância entre os achados anatomopatológicos e imagenológicos em 89 dos casos. A sensibilidade da biópsia de fragmento para o diagnóstico do câncer de mama foi de 98,8% e a especificidade foi de 100%. COnClusões: os resultados obtidos pela biópsia de fragmento guiada pela ultra-sonografia em nódulos sólidos de até 10 mm nesse trabalho são semelhantes aos melhores resultados de qualquer tipo de biópsia na literatura. Portanto, nódulos menores que 10 mm podem ser abordados histologicamente pela biópsia de fragmento com segurança. AbstractPuRPOse: to evaluate the diagnostic efficacy of core needle biopsy in suspicious solid breast masses (Bi-Rads ™ 4 or 5) up to 10 mm. MethOds: this study was conducted on 83 women diagnosed with 90 suspicious solid lumps, all measuring up to 10 mm, identified by mammography (41), sonography (47) or palpation (two), who visited our clinic from September 2003 to January 2006. The lesions were biopsied with automatic device and 14 gauge needle (Bard, Corington, GA), all of them ultrasound guided. According to the pathological report, the biopsies were classified as true-positives, false-positives, true-negatives, and false-negatives. The sensitivity and specificity of ultrasound-guided core biopsy in breast masses up to 1 cm were calculated. Results: the mean patient age was 52.5 years, and the mean diameter of the lesions was 7.3 mm, ranging from 3 to 10 mm. The results yielded by the pathologist showed 40 benign lesions (44.4%), 49 malignant lesions (54.4%) and one case (1.1%) of inconclusive material. This patient was submitted to ultrasound guided core needle biopsy once again, this time with conclusive results. There was agreement between histology and radiology in 89 cases. Sensitivity of ultrasound guided core biopsy for the diagnosis of breast cancer was 98.8 % and specificity 100%. COnClusiOns: the results obtained by ultrasound-guided core biopsy in suspicious breast lesions up to 10 mm are comparable to the best results of any kind of biopsy in the literature. Therefore, even solid lesions smaller or equal to 10 mm can be safely evaluated pathologically by core biopsy. Palavras-chaveNeoplasias mamárias/patologia Neoplasias mamárias/ultra-sonografia Neoplasias mamárias/diagnóstico Biópsia KeywordsBreast neoplasms/pathology Breast neoplasms/ultrasonography Breast neoplasms/diagnosis Biopsy
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.